{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:07:17Z","timestamp":1794874037375,"version":"4.9.1"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NINDS RFA-NS-16-012"],"award-info":[{"award-number":["NINDS RFA-NS-16-012"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurological heterotopic ossification (NHO) is a debilitating condition where bone forms in soft tissue, such as muscle surrounding the hip and knee, following an injury to the brain or spinal cord. This abnormal formation of bone can result in nerve impingement, pain, contractures and impaired movement. Patients are often diagnosed with NHO after the bone tissue has completely mineralised, leaving invasive surgical resection the only remaining treatment option. Surgical resection of NHO creates potential for added complications, particularly in patients with concomitant injury to the central nervous system (CNS). Although recent work has begun to shed light on the physiological mechanisms involved in NHO, there remains a significant knowledge gap related to the prognostic biomarkers and prophylactic treatments which are necessary to prevent NHO and optimise patient outcomes. This article reviews the current understanding pertaining to NHO epidemiology, pathobiology, biomarkers and treatment options. In particular, we focus on how concomitant CNS injury may drive ectopic bone formation and discuss considerations for treating polytrauma patients with NHO. We conclude that understanding of the pathogenesis of NHO is rapidly advancing, and as such, there is the strong potential for future research to unearth methods capable of identifying patients likely to develop NHO, and targeted treatments to prevent its manifestation.<\/jats:p>","DOI":"10.1038\/s41413-020-00119-9","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T09:43:00Z","timestamp":1607506980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-0672","authenticated-orcid":false,"given":"Ker Rui","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richelle","family":"Mychasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence J.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy R.","family":"Shultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys D.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"119_CR1","doi-asserted-by":"crossref","unstructured":"Garland, D. E. A clinical perspective on common forms of acquired heterotopic ossification. Clin. Orthop. Relat. Res. 263, 13\u201329 (1991).","DOI":"10.1097\/00003086-199102000-00003"},{"key":"119_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bone.2018.02.009","volume":"109","author":"BW Hoyt","year":"2018","unstructured":"Hoyt, B. W., Pavey, G. J., Potter, B. K. & Forsberg, J. A. Heterotopic ossification and lessons learned from fifteen years at war: a review of therapy, novel research, and future directions for military and civilian orthopaedic trauma. Bone 109, 3\u201311 (2018).","journal-title":"Bone"},{"key":"119_CR3","first-page":"258","volume":"73","author":"TJ Citta-Pietrolungo","year":"1992","unstructured":"Citta-Pietrolungo, T. J., Alexander, M. A. & Steg, N. L. Early detection of heterotopic ossification in young patients with traumatic brain injury. Arch. Phys. Med. Rehabil. 73, 258\u2013262 (1992).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"119_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3928\/01477447-20110124-08","volume":"34","author":"AF Mavrogenis","year":"2011","unstructured":"Mavrogenis, A. F., Soucacos, P. N. & Papagelopoulos, P. J. Heterotopic ossification revisited. Orthopedics 34, 177 (2011).","journal-title":"Orthopedics"},{"key":"119_CR5","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3109\/02699052.2015.1075171","volume":"29","author":"E Adiguzel","year":"2015","unstructured":"Adiguzel, E. et al. Knee pain relief with genicular nerve blockage in two brain injured patients with heterotopic ossification. Brain Inj. 29, 1736\u20131739 (2015).","journal-title":"Brain Inj."},{"key":"119_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bone.2017.05.015","volume":"109","author":"RD Brady","year":"2018","unstructured":"Brady, R. D., Shultz, S. R., McDonald, S. J. & O\u2019Brien, T. J. Neurological heterotopic ossification: current understanding and future directions. Bone 109, 35\u201342 (2018).","journal-title":"Bone"},{"key":"119_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bone.2017.07.016","volume":"109","author":"EL Davis","year":"2018","unstructured":"Davis, E. L., Davis, A. R., Gugala, Z. & Olmsted-Davis, E. A. Is heterotopic ossification getting nervous?: the role of the peripheral nervous system in heterotopic ossification. Bone 109, 22\u201327 (2018).","journal-title":"Bone"},{"key":"119_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016632","volume":"6","author":"F Gen\u00eat","year":"2011","unstructured":"Gen\u00eat, F. et al. Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS ONE 6, e16632 (2011).","journal-title":"PLoS ONE"},{"key":"119_CR9","first-page":"34","volume":"15","author":"B Maheswarappa","year":"2004","unstructured":"Maheswarappa, B., Nair, K., Taly, A., Shanthi, S. & Murali, T. Heterotopic ossification at unusual site in traumatic brain injury. IJPMR 15, 34\u201337 (2004).","journal-title":"IJPMR"},{"key":"119_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.5435\/00124635-200911000-00003","volume":"17","author":"CA Cipriano","year":"2009","unstructured":"Cipriano, C. A., Pill, S. G. & Keenan, M. A. Heterotopic ossification following traumatic brain injury and spinal cord injury. J. Am. Acad. Orthop. Surg. 17, 689\u2013697 (2009).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"119_CR11","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/BOT.0b013e3182724624","volume":"26","author":"A Nauth","year":"2012","unstructured":"Nauth, A. et al. Heterotopic ossification in orthopaedic trauma. J. Orthop. Trauma 26, 684\u2013688 (2012).","journal-title":"J. Orthop. Trauma"},{"key":"119_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/path.4519","volume":"236","author":"F Gen\u00eat","year":"2015","unstructured":"Gen\u00eat, F. et al. Neurological heterotopic ossification following spinal cord injury is triggered by macrophage\u2010mediated inflammation in muscle. J. Pathol. 236, 229\u2013240 (2015).","journal-title":"J. Pathol."},{"key":"119_CR13","doi-asserted-by":"publisher","first-page":"100222","DOI":"10.1016\/j.bonr.2019.100222","volume":"11","author":"M Jodoin","year":"2019","unstructured":"Jodoin, M. et al. Investigating the incidence and magnitude of heterotopic ossification with and without joints involvement in patients with a limb fracture and mild traumatic brain injury. Bone Rep. 11, 100222 (2019).","journal-title":"Bone Rep."},{"key":"119_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00256-014-2003-6","volume":"44","author":"M Salga","year":"2015","unstructured":"Salga, M. et al. Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications. Skelet. Radiol. 44, 233\u2013240 (2015).","journal-title":"Skelet. Radiol."},{"key":"119_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000343275","volume":"40","author":"RB Frost","year":"2013","unstructured":"Frost, R. B., Farrer, T. J., Primosch, M. & Hedges, D. W. Prevalence of traumatic brain injury in the general adult population: a meta-analysis. Neuroepidemiology 40, 154\u2013159 (2013).","journal-title":"Neuroepidemiology"},{"key":"119_CR16","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1097\/PRS.0000000000001266","volume":"135","author":"K Ranganathan","year":"2015","unstructured":"Ranganathan, K. et al. Role of gender in burn-induced heterotopic ossification and mesenchymal cell osteogenic differentiation. Plast. Reconstr. Surg. 135, 1631\u20131641 (2015).","journal-title":"Plast. Reconstr. Surg."},{"key":"119_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/rheumatology\/20.4.193","volume":"20","author":"JM Larson","year":"1981","unstructured":"Larson, J. M. et al. Increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic spinal cord injury. Rheumatology 20, 193\u2013197 (1981).","journal-title":"Rheumatology"},{"key":"119_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/rheumatology\/19.2.97","volume":"19","author":"T Hunter","year":"1980","unstructured":"Hunter, T., Dubo, H., Hildahl, C., Smith, N. & Schroeder, M. Histocompatibility antigens in patients with spinal cord injury or cerebral damage complicated by heterotopic ossification. Rheumatology 19, 97\u201399 (1980).","journal-title":"Rheumatology"},{"key":"119_CR19","first-page":"230","volume":"12","author":"V Sakellariou","year":"2012","unstructured":"Sakellariou, V., Grigoriou, E., Mavrogenis, A., Soucacos, P. & Papagelopoulos, P. Heterotopic ossification following traumatic brain injury and spinal cord injury: insight into the etiology and pathophysiology. J. Musculoskelet. Neuronal Interact. 12, 230\u2013240 (2012).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"119_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3109\/02699052.2013.775490","volume":"27","author":"D Dizdar","year":"2013","unstructured":"Dizdar, D. et al. Risk factors for developing heterotopic ossification in patients with traumatic brain injury. Brain Inj. 27, 807\u2013811 (2013).","journal-title":"Brain Inj."},{"key":"119_CR21","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.injury.2007.03.019","volume":"38","author":"LL Simonsen","year":"2007","unstructured":"Simonsen, L. L., Sonne-Holm, S., Krasheninnikoff, M. & Engberg, A. W. Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: incidence and risk factors. Injury 38, 1146\u20131150 (2007).","journal-title":"Injury"},{"key":"119_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/HTR.0b013e3181f78a59","volume":"26","author":"P Van Kampen","year":"2011","unstructured":"Van Kampen, P., Martina, J., Vos, P., Hoedemaekers, C. & Hendricks, H. Potential risk factors for developing heterotopic ossification in patients with severe traumatic brain injury. J. Head Trauma Rehabil. 26, 384\u2013391 (2011).","journal-title":"J. Head Trauma Rehabil."},{"key":"119_CR23","unstructured":"Forsberg, J. A. & Potter, B. K. Heterotopic Ossification in Wartime Wounds. J. Surg. Orthop. Adv. Spring. 19, 54\u201361 (2010)."},{"key":"119_CR24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1176\/jnp.2006.18.2.141","volume":"18","author":"KH Taber","year":"2006","unstructured":"Taber, K. H., Warden, D. L. & Hurley, R. A. Blast-related traumatic brain injury: what is known?. J. Neuropsychiatry Clin. Neurosci. 18, 141\u2013145 (2006).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"119_CR25","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S1474-4422(13)70161-3","volume":"12","author":"JV Rosenfeld","year":"2013","unstructured":"Rosenfeld, J. V. et al. Blast-related traumatic brain injury. Lancet Neurol. 12, 882\u2013893 (2013).","journal-title":"Lancet Neurol."},{"key":"119_CR26","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2106\/JBJS.H.00792","volume":"91","author":"JA Forsberg","year":"2009","unstructured":"Forsberg, J. A. et al. Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J. Bone Jt. Surg. Am. 91, 1084\u20131091 (2009).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1526-4637.2009.00589.x","volume":"10","author":"ME Clark","year":"2009","unstructured":"Clark, M. E., Scholten, J. D., Walker, R. L. & Gironda, R. J. Assessment and treatment of pain associated with combat-related polytrauma. Pain Med. 10, 456\u2013469 (2009).","journal-title":"Pain Med."},{"key":"119_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fneur.2019.00282","volume":"10","author":"A Alizadeh","year":"2019","unstructured":"Alizadeh, A., Dyck, S. M. & Karimi-Abdolrezaee, S. Traumatic spinal cord injury: an overview of pathophysiology, models and acute injury mechanisms. Front. Neurol. 10, 282 (2019).","journal-title":"Front. Neurol."},{"key":"119_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11845-016-1399-5","volume":"185","author":"E Smith","year":"2016","unstructured":"Smith, E., Comiskey, C. & Carroll, A. Prevalence of and risk factors for osteoporosis in adults with acquired brain injury. Ir. J. Med. Sci. 185, 473\u2013481 (2016).","journal-title":"Ir. J. Med. Sci."},{"key":"119_CR30","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","volume":"7","author":"AI Maas","year":"2008","unstructured":"Maas, A. I., Stocchetti, N. & Bullock, R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728\u2013741 (2008).","journal-title":"Lancet Neurol."},{"key":"119_CR31","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.neuron.2012.11.021","volume":"76","author":"K Blennow","year":"2012","unstructured":"Blennow, K., Hardy, J. & Zetterberg, H. The neuropathology and neurobiology of traumatic brain injury. Neuron 76, 886\u2013899 (2012).","journal-title":"Neuron"},{"key":"119_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jnr.23300","volume":"92","author":"JL Alves","year":"2014","unstructured":"Alves, J. L. Blood-brain barrier and traumatic brain injury. J. Neurosci. Res. 92, 141\u2013147 (2014).","journal-title":"J. Neurosci. Res."},{"key":"119_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157015908785777210","volume":"6","author":"SM Stamatovic","year":"2008","unstructured":"Stamatovic, S. M., Keep, R. F. & Andjelkovic, A. V. Brain endothelial cell-cell junctions: how to \u201copen\u201d the blood brain barrier. Curr. Neuropharmacol. 6, 179\u2013192 (2008).","journal-title":"Curr. Neuropharmacol."},{"key":"119_CR34","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1172\/JCI41911","volume":"120","author":"EH Wilson","year":"2010","unstructured":"Wilson, E. H., Weninger, W. & Hunter, C. A. Trafficking of immune cells in the central nervous system. J. Clin. Investig. 120, 1368\u20131379 (2010).","journal-title":"J. Clin. Investig."},{"key":"119_CR35","doi-asserted-by":"crossref","unstructured":"Wolburg, H., Wolburg-Buchholz, K. & Engelhardt, B. Involvement of tight junctions during transendothelial migration of mononuclear cells in experimental autoimmune encephalomyelitis. Ernst Schering Res. Found. Workshop. 47,17\u201338 (2004).","DOI":"10.1007\/978-3-662-05426-0_2"},{"key":"119_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrneurol.2010.74","volume":"6","author":"D Shlosberg","year":"2010","unstructured":"Shlosberg, D., Benifla, M., Kaufer, D. & Friedman, A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393\u2013403 (2010).","journal-title":"Nat. Rev. Neurol."},{"key":"119_CR37","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2106\/00004623-199072080-00004","volume":"72","author":"SM Bidner","year":"1990","unstructured":"Bidner, S. M., Rubins, I. M., Desjardins, J. V., Zukor, D. J. & Goltzman, D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J. Bone Jt. Surg. Am. 72, 1144\u20131149 (1990).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/neu.2006.0166","volume":"24","author":"OP Gautschi","year":"2007","unstructured":"Gautschi, O. P. et al. Osteoinductive effect of cerebrospinal fluid from brain-injured patients. J. Neurotrauma 24, 154\u2013162 (2007).","journal-title":"J. Neurotrauma"},{"key":"119_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fendo.2018.00008","volume":"9","author":"M Quinn","year":"2018","unstructured":"Quinn, M. & Agha, A. Post-traumatic hypopituitarism\u2014who should be screened, when, and how? Front. Endocrinol. 9, 8 (2018).","journal-title":"Front. Endocrinol."},{"key":"119_CR40","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/jnnp-2016-315500","volume":"88","author":"CL Tan","year":"2017","unstructured":"Tan, C. L. et al. The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance. J. Neurol. Neurosurg. Psychiatry 88, 971\u2013981 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"119_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","volume":"22","author":"BC Silva","year":"2015","unstructured":"Silva, B. C. & Bilezikian, J. P. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Curr. Opin. Pharmacol. 22, 41\u201350 (2015).","journal-title":"Curr. Opin. Pharmacol."},{"key":"119_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mce.2015.09.017","volume":"432","author":"RC Lindsey","year":"2016","unstructured":"Lindsey, R. C. & Mohan, S. Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol. Cell. Endocrinol. 432, 44\u201355 (2016).","journal-title":"Mol. Cell. Endocrinol."},{"key":"119_CR43","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2106\/JBJS.G.01613","volume":"91","author":"D Cadosch","year":"2009","unstructured":"Cadosch, D. et al. Humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury. J. Bone Jt. Surg. Am. 91, 282\u2013288 (2009).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR44","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.injury.2006.08.020","volume":"37","author":"PV Giannoudis","year":"2006","unstructured":"Giannoudis, P. V. et al. Accelerated bone healing and excessive callus formation in patients with femoral fracture and head injury. Injury 37, S18\u2013S24 (2006).","journal-title":"Injury"},{"key":"119_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1302\/0301-620X.69B4.3611150","volume":"69","author":"R Perkins","year":"1987","unstructured":"Perkins, R. & Skirving, A. Callus formation and the rate of healing of femoral fractures in patients with head injuries. J. Bone Jt. Surg. Br. 69, 521\u2013524 (1987).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR46","first-page":"309","volume":"15","author":"RJ Locher","year":"2015","unstructured":"Locher, R. J. et al. Traumatic brain injury and bone healing: radiographic and biomechanical analyses of bone formation and stability in a combined murine trauma model. J. Musculoskelet. Neuronal Interact. 15, 309\u2013315 (2015).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"119_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.injury.2015.01.044","volume":"46","author":"S Tsitsilonis","year":"2015","unstructured":"Tsitsilonis, S. et al. The effect of traumatic brain injury on bone healing: an experimental study in a novel in vivo animal model. Injury 46, 661\u2013665 (2015).","journal-title":"Injury"},{"key":"119_CR48","first-page":"7","volume":"14","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. Effect of leptin on bone metabolism in rat model of traumatic brain injury and femoral fracture. Chin. J. Traumatol. 14, 7\u201313 (2011).","journal-title":"Chin. J. Traumatol."},{"key":"119_CR49","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1211\/jpp.60.12.0013","volume":"60","author":"Y Wei","year":"2008","unstructured":"Wei, Y., Wang, L., Clark, J. C., Dass, C. R. & Choong, P. F. Elevated leptin expression in a rat model of fracture and traumatic brain injury. J. Pharm. Pharmacol. 60, 1667\u20131672 (2008).","journal-title":"J. Pharm. Pharmacol."},{"key":"119_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054077","volume":"8","author":"X Liu","year":"2013","unstructured":"Liu, X. et al. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. PloS ONE 8, e54077 (2013).","journal-title":"PloS ONE"},{"key":"119_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep34491","volume":"6","author":"RD Brady","year":"2016","unstructured":"Brady, R. D. et al. Closed head experimental traumatic brain injury increases size and bone volume of callus in mice with concomitant tibial fracture. Sci. Rep. 6, 34491 (2016).","journal-title":"Sci. Rep."},{"key":"119_CR52","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1179\/2045772313Y.0000000155","volume":"37","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. The effects of spinal cord injury on bone healing in patients with femoral fractures. J. Spinal Cord Med. 37, 414\u2013419 (2014).","journal-title":"J. Spinal Cord Med."},{"key":"119_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"K Morioka","year":"2019","unstructured":"Morioka, K. et al. Differential fracture response to traumatic brain injury suggests dominance of neuroinflammatory response in polytrauma. Sci. Rep. 9, 1\u201316 (2019).","journal-title":"Sci. Rep."},{"key":"119_CR54","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1089\/neu.2014.3836","volume":"33","author":"RD Brady","year":"2016","unstructured":"Brady, R. D. et al. Experimental traumatic brain injury induces bone loss in rats. J. Neurotrauma 33, 2154\u20132160 (2016).","journal-title":"J. Neurotrauma"},{"key":"119_CR55","first-page":"369","volume":"16","author":"R Brady","year":"2016","unstructured":"Brady, R. et al. Sodium selenate treatment mitigates reduction of bone volume following traumatic brain injury in rats. J. Musculoskelet. Neuronal Interact. 16, 369\u2013376 (2016).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"119_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5435\/00124635-200403000-00007","volume":"12","author":"FS Kaplan","year":"2004","unstructured":"Kaplan, F. S., Glaser, D. L., Hebela, N. & Shore, E. M. Heterotopic ossification. J. Am. Acad. Orthop. Surg. 12, 116\u2013125 (2004).","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"119_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdsr.2013.07.003","volume":"50","author":"K Shimono","year":"2014","unstructured":"Shimono, K., Uchibe, K., Kuboki, T. & Iwamoto, M. The pathophysiology of heterotopic ossification: current treatment considerations in dentistry. Jpn. Dent. Sci. Rev. 50, 1\u20138 (2014).","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"119_CR58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/jramc-2014-000277","volume":"161","author":"DS Edwards","year":"2015","unstructured":"Edwards, D. S. & Clasper, J. Heterotopic ossification: a systematic review. J. R. Army Med. Corps 161, 315\u2013321 (2015).","journal-title":"J. R. Army Med. Corps"},{"key":"119_CR59","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nrrheum.2010.122","volume":"6","author":"EM Shore","year":"2010","unstructured":"Shore, E. M. & Kaplan, F. S. Inherited human diseases of heterotopic bone formation. Nat. Rev. Rheumatol. 6, 518\u2013527 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"119_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bone.2017.04.014","volume":"109","author":"C Kan","year":"2018","unstructured":"Kan, C. et al. Conserved signaling pathways underlying heterotopic ossification. Bone 109, 43\u201348 (2018).","journal-title":"Bone"},{"key":"119_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41413-019-0075-6","volume":"7","author":"C Hwang","year":"2019","unstructured":"Hwang, C. et al. Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification. Bone Res. 7, 1\u201317 (2019).","journal-title":"Bone Res."},{"key":"119_CR62","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bone.2005.04.040","volume":"37","author":"JC Robins","year":"2005","unstructured":"Robins, J. C. et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37, 313\u2013322 (2005).","journal-title":"Bone"},{"key":"119_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bone.2014.09.017","volume":"70","author":"S Stegen","year":"2015","unstructured":"Stegen, S., van Gastel, N. & Carmeliet, G. Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone 70, 19\u201327 (2015).","journal-title":"Bone"},{"key":"119_CR64","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s11999-015-4240-y","volume":"473","author":"AT Qureshi","year":"2015","unstructured":"Qureshi, A. T. et al. Early characterization of blast-related heterotopic ossification in a rat model. Clin. Orthop. Relat. Res. 473, 2831\u20132839 (2015).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"119_CR65","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1089\/scd.2015.0135","volume":"24","author":"S Agarwal","year":"2015","unstructured":"Agarwal, S. et al. Diminished chondrogenesis and enhanced osteoclastogenesis in leptin-deficient diabetic mice (ob\/ob) impair pathologic, trauma-induced heterotopic ossification. Stem Cells Dev. 24, 2864\u20132872 (2015).","journal-title":"Stem Cells Dev."},{"key":"119_CR66","doi-asserted-by":"crossref","unstructured":"Allen, M. R. & Burr, D. B. in Basic and Applied Bone Biology (eds David, B. Burr & Matthew, R. Allen) 75\u201390 (Academic Press, 2014).","DOI":"10.1016\/B978-0-12-416015-6.00004-6"},{"key":"119_CR67","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1302\/0301-620X.57B1.36","volume":"57","author":"J Chalmers","year":"1975","unstructured":"Chalmers, J., Gray, D. & Rush, J. Observations on the induction of bone in soft tissues. J. Bone Jt. Surg. Br. 57, 36\u201345 (1975).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00223-015-0034-1","volume":"97","author":"OG Davies","year":"2015","unstructured":"Davies, O. G., Grover, L. M., Eisenstein, N., Lewis, M. P. & Liu, Y. Identifying the cellular mechanisms leading to heterotopic ossification. Calcif. Tissue Int. 97, 432\u2013444 (2015).","journal-title":"Calcif. Tissue Int."},{"key":"119_CR69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bone.2018.01.029","volume":"109","author":"JB Lees-Shepard","year":"2018","unstructured":"Lees-Shepard, J. B. & Goldhamer, D. J. Stem cells and heterotopic ossification: lessons from animal models. Bone 109, 178\u2013186 (2018).","journal-title":"Bone"},{"key":"119_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bone.2017.12.006","volume":"109","author":"KL Foley","year":"2018","unstructured":"Foley, K. L., Hebela, N., Keenan, M. A. & Pignolo, R. J. Histopathology of periarticular non-hereditary heterotopic ossification. Bone 109, 65\u201370 (2018).","journal-title":"Bone"},{"key":"119_CR71","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.trsl.2017.06.004","volume":"186","author":"D Dey","year":"2017","unstructured":"Dey, D. et al. The traumatic bone: trauma-induced heterotopic ossification. Transl. Res. 186, 95\u2013111 (2017).","journal-title":"Transl. Res."},{"key":"119_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10172","volume":"3","author":"C Meyers","year":"2019","unstructured":"Meyers, C. et al. Heterotopic ossification: a comprehensive review. JBMR Plus 3, e10172 (2019).","journal-title":"JBMR Plus"},{"key":"119_CR73","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/1440-1681.13025","volume":"45","author":"P \u0141\u0119gosz","year":"2018","unstructured":"\u0141\u0119gosz, P., Drela, K., Pulik, \u0141., Sarzy\u0144ska, S. & Ma\u0142dyk, P. Challenges of heterotopic ossification\u2014molecular background and current treatment strategies. Clin. Exp. Pharmacol. Physiol. 45, 1229\u20131235 (2018).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"119_CR74","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2106\/JBJS.N.01056","volume":"97","author":"K Ranganathan","year":"2015","unstructured":"Ranganathan, K. et al. Heterotopic ossification: basic-science principles and clinical correlates. J. Bone Jt. Surg. Br. 97, 1101\u20131111 (2015).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR75","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.bone.2017.08.025","volume":"109","author":"R Xu","year":"2018","unstructured":"Xu, R., Hu, J., Zhou, X. & Yang, Y. Heterotopic ossification: mechanistic insights and clinical challenges. Bone 109, 134\u2013142 (2018).","journal-title":"Bone"},{"key":"119_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-14172-4","volume":"11","author":"M Sorkin","year":"2020","unstructured":"Sorkin, M. et al. Regulation of heterotopic ossification by monocytes in a mouse model of aberrant wound healing. Nat. Commun. 11, 1\u201317 (2020).","journal-title":"Nat. Commun."},{"key":"119_CR77","doi-asserted-by":"crossref","unstructured":"Tseng, H. W. et al. Neurogenic heterotopic ossifications develop independently of granulocyte\u2010colony stimulating factor and neutrophils. J. Bone Miner. Res. 1\u201310 (2020).","DOI":"10.1002\/jbmr.4118"},{"key":"119_CR78","doi-asserted-by":"crossref","unstructured":"Torossian, F. et al. Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications. JCI Insight 2, e96034 (2017).","DOI":"10.1172\/jci.insight.96034"},{"key":"119_CR79","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/stem.150","volume":"27","author":"RK Suda","year":"2009","unstructured":"Suda, R. K. et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells 27, 2209\u20132219 (2009).","journal-title":"Stem Cells"},{"key":"119_CR80","doi-asserted-by":"crossref","unstructured":"Sims, N. A. & Quinn, J. M. Osteoimmunology: oncostatin M as a pleiotropic regulator of bone formation and resorption in health and disease. Bonekey Rep. 3, 527 (2014).","DOI":"10.1038\/bonekey.2014.22"},{"key":"119_CR81","doi-asserted-by":"publisher","first-page":"115263","DOI":"10.1016\/j.bone.2020.115263","volume":"133","author":"RD Brady","year":"2020","unstructured":"Brady, R. D. et al. A novel rat model of heterotopic ossification after polytrauma with traumatic brain injury. Bone 133, 115263 (2020).","journal-title":"Bone"},{"key":"119_CR82","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/sj.sc.3101483","volume":"41","author":"OB Hausmann","year":"2003","unstructured":"Hausmann, O. B. Post-traumatic inflammation following spinal cord injury. Spinal Cord 41, 369\u2013378 (2003).","journal-title":"Spinal Cord"},{"key":"119_CR83","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12975-011-0125-x","volume":"2","author":"A Chodobski","year":"2011","unstructured":"Chodobski, A., Zink, B. J. & Szmydynger-Chodobska, J. Blood\u2013brain barrier pathophysiology in traumatic brain injury. Transl. Stroke Res. 2, 492\u2013516 (2011).","journal-title":"Transl. Stroke Res."},{"key":"119_CR84","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bja\/aem131","volume":"99","author":"C Werner","year":"2007","unstructured":"Werner, C. & Engelhard, K. Pathophysiology of traumatic brain injury. BJA Br. J. Anaesth. 99, 4\u20139 (2007).","journal-title":"BJA Br. J. Anaesth."},{"key":"119_CR85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.npep.2003.12.003","volume":"38","author":"A Nimmo","year":"2004","unstructured":"Nimmo, A. et al. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38, 40\u201347 (2004).","journal-title":"Neuropeptides"},{"key":"119_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fneur.2018.00115","volume":"9","author":"NM Bajwa","year":"2018","unstructured":"Bajwa, N. M., Kesavan, C. & Mohan, S. Long-term consequences of traumatic brain injury in bone metabolism. Front. Neurol. 9, 115 (2018).","journal-title":"Front. Neurol."},{"key":"119_CR87","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev.me.40.020189.002013","volume":"40","author":"DG Payan","year":"1989","unstructured":"Payan, D. G. Neuropeptides and inflammation: the role of substance P. Annu. Rev. Med. 40, 341\u2013352 (1989).","journal-title":"Annu. Rev. Med."},{"key":"119_CR88","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1902\/jop.2004.75.7.974","volume":"75","author":"H Azuma","year":"2004","unstructured":"Azuma, H., Kido, Ji, Ikedo, D., Kataoka, M. & Nagata, T. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from porphyromonas gingivalis. J. Periodontol. 75, 974\u2013981 (2004).","journal-title":"J. Periodontol."},{"key":"119_CR89","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/jcb.23259","volume":"112","author":"L Kan","year":"2011","unstructured":"Kan, L. et al. Substance P signaling mediates BMP\u2010dependent heterotopic ossification. J. Cell. Biochem. 112, 2759\u20132772 (2011).","journal-title":"J. Cell. Biochem."},{"key":"119_CR90","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/jcb.23225","volume":"112","author":"E Salisbury","year":"2011","unstructured":"Salisbury, E. et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J. Cell. Biochem. 112, 2748\u20132758 (2011).","journal-title":"J. Cell. Biochem."},{"key":"119_CR91","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.npep.2006.11.002","volume":"41","author":"T Goto","year":"2007","unstructured":"Goto, T. et al. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41, 25\u201331 (2007).","journal-title":"Neuropeptides"},{"key":"119_CR92","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0306-4522(90)90386-I","volume":"38","author":"HS Sharma","year":"1990","unstructured":"Sharma, H. S., Nyberg, F., Olsson, Y. & Dey, P. K. Alteration of substance P after trauma to the spinal cord: an experimental study in the rat. Neuroscience 38, 205\u2013212 (1990).","journal-title":"Neuroscience"},{"key":"119_CR93","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0079-6123(06)61007-8","volume":"161","author":"JJ Donkin","year":"2007","unstructured":"Donkin, J. J., Turner, R. J., Hassan, I. & Vink, R. Substance P in traumatic brain injury. Prog. Brain Res. 161, 97\u2013109 (2007).","journal-title":"Prog. Brain Res."},{"key":"119_CR94","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1002\/jbmr.1691","volume":"27","author":"D Medici","year":"2012","unstructured":"Medici, D. & Olsen, B. R. The role of endothelial\u2010mesenchymal transition in heterotopic ossification. J. Bone Miner. Res. 27, 1619\u20131622 (2012).","journal-title":"J. Bone Miner. Res."},{"key":"119_CR95","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhsa.2013.09.029","volume":"39","author":"LM Reichel","year":"2014","unstructured":"Reichel, L. M., Salisbury, E., Moustoukas, M. J., Davis, A. R. & Olmsted-Davis, E. Molecular mechanisms of heterotopic ossification. J. Hand Surg. 39, 563\u2013566 (2014).","journal-title":"J. Hand Surg."},{"key":"119_CR96","doi-asserted-by":"crossref","unstructured":"Salisbury, E., Sonnet, C., Heggeness, M., Davis, A. R. & Olmsted-Davis, E. Heterotopic ossification has some nerve. Crit. Rev. Eukaryot. Gene Expr. 20, 313\u2013324 (2010).","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i4.30"},{"key":"119_CR97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10571-016-0400-1","volume":"37","author":"ML Pearn","year":"2017","unstructured":"Pearn, M. L. et al. Pathophysiology associated with traumatic brain injury: current treatments and potential novel therapeutics. Cell. Mol. Neurobiol. 37, 571\u2013585 (2017).","journal-title":"Cell. Mol. Neurobiol."},{"key":"119_CR98","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.nurt.2009.10.018","volume":"7","author":"R Vink","year":"2010","unstructured":"Vink, R. & van den Heuvel, C. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics 7, 74\u201380 (2010).","journal-title":"Neurotherapeutics"},{"key":"119_CR99","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Hern\u00e1ndez, A. et al. Heteroreceptors modulating CGRP release at neurovascular junction: potential therapeutic implications on some vascular-related diseases. Biomed Res. Int. 2016, 2056786 (2016).","DOI":"10.1155\/2016\/2056786"},{"key":"119_CR100","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jemt.10122","volume":"58","author":"K Irie","year":"2002","unstructured":"Irie, K., Hara\u2010Irie, F., Ozawa, H. & Yajima, T. Calcitonin gene\u2010related peptide (CGRP)\u2010containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc. Res. Tech. 58, 85\u201390 (2002).","journal-title":"Microsc. Res. Tech."},{"key":"119_CR101","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1080\/21691401.2019.1626865","volume":"47","author":"X Sang","year":"2019","unstructured":"Sang, X., Wang, Z., Shi, P., Li, Y. & Cheng, L. CGRP accelerates the pathogenesis of neurological heterotopic ossification following spinal cord injury. Artif. Cells Nanomed. Biotechnol. 47, 2569\u20132574 (2019).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"119_CR102","first-page":"432","volume":"5","author":"Y Song","year":"2012","unstructured":"Song, Y. et al. Increased levels of calcitonin gene-related peptide in serum accelerate fracture healing following traumatic brain injury. Mol. Med. Rep. 5, 432\u2013438 (2012).","journal-title":"Mol. Med. Rep."},{"key":"119_CR103","first-page":"1522","volume":"21","author":"Y Song","year":"2017","unstructured":"Song, Y. et al. The role of the hippocampus and the function of calcitonin gene-related peptide in the mechanism of traumatic brain injury accelerating fracture-healing. Eur. Rev. Med. Pharmacol. Sci. 21, 1522\u20131531 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"119_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/10731190902743149","volume":"37","author":"D Zhang","year":"2009","unstructured":"Zhang, D. et al. The influence of brain injury or peripheral nerve injury on calcitonin gene-related peptide concentration variation and fractures healing process. Artif. Cells Blood Substit. Biotechnol. 37, 85\u201391 (2009).","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"key":"119_CR105","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1146\/annurev.neuro.24.1.1217","volume":"24","author":"MV Sofroniew","year":"2001","unstructured":"Sofroniew, M. V., Howe, C. L. & Mobley, W. C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217\u20131281 (2001).","journal-title":"Annu. Rev. Neurosci."},{"key":"119_CR106","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1016\/j.celrep.2016.08.002","volume":"16","author":"RyanE Tomlinson","year":"2016","unstructured":"Tomlinson, RyanE. et al. NGF-TrkA signaling by sensory nerves coordinates the vascularization and ossification of developing endochondral bone. Cell Rep. 16, 2723\u20132735 (2016).","journal-title":"Cell Rep."},{"key":"119_CR107","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/17453679808999059","volume":"69","author":"BL Grills","year":"1998","unstructured":"Grills, B. L. & Schuijers, J. A. Immunohistochemical localization of nerve growth factor in fractured and unfractured rat bone. Acta Orthop. Scand. 69, 415\u2013419 (1998).","journal-title":"Acta Orthop. Scand."},{"key":"119_CR108","first-page":"2439","volume":"22","author":"X Li","year":"2018","unstructured":"Li, X., Sun, D., Li, Y. & Wu, X. Neurotrophin-3 improves fracture healing in rats. Eur. Rev. Med. Pharmacol. Sci. 22, 2439\u20132446 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"119_CR109","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S8756-3282(00)00281-7","volume":"26","author":"K Asaumi","year":"2000","unstructured":"Asaumi, K., Nakanishi, T., Asahara, H., Inoue, H. & Takigawa, M. Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone 26, 625\u2013633 (2000).","journal-title":"Bone"},{"key":"119_CR110","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Macrophage-derived neurotrophin-3 promotes heterotopic ossification in rats. Lab. Investig. 100, 762\u2013776 (2020).","DOI":"10.1038\/s41374-019-0367-x"},{"key":"119_CR111","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1177\/0192623317738708","volume":"45","author":"A Corr","year":"2017","unstructured":"Corr, A., Smith, J. & Baldock, P. Neuronal control of bone remodeling. Toxicol. Pathol. 45, 894\u2013903 (2017).","journal-title":"Toxicol. Pathol."},{"key":"119_CR112","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.3390\/ijms21144946","volume":"21","author":"E Otto","year":"2020","unstructured":"Otto, E. et al. Crosstalk of brain and bone\u2014clinical observations and their molecular bases. Int. J. Mol. Sci. 21, 4946 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"119_CR113","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0092-8674(02)01049-8","volume":"111","author":"S Takeda","year":"2002","unstructured":"Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305\u2013317 (2002).","journal-title":"Cell"},{"key":"119_CR114","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3928\/01477447-20070601-18","volume":"30","author":"ST Chao","year":"2007","unstructured":"Chao, S. T., Joyce, M. J. & Suh, J. H. Treatment of heterotopic ossification. Orthopedics 30, 457\u2013464 (2007).","journal-title":"Orthopedics"},{"key":"119_CR115","first-page":"346","volume":"43","author":"D Shehab","year":"2002","unstructured":"Shehab, D., Elgazzar, A. H. & Collier, B. D. Heterotopic ossification. J. Nucl. Med. 43, 346\u2013353 (2002).","journal-title":"J. Nucl. Med."},{"key":"119_CR116","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1097\/00005373-200006000-00010","volume":"48","author":"T Ebinger","year":"2000","unstructured":"Ebinger, T., Roesch, M., Kiefer, H., Kinzl, L. & Schulte, M. Influence of etiology in heterotopic bone formation of the hip. J. Trauma Acute Care Surg. 48, 1058\u20131062 (2000).","journal-title":"J. Trauma Acute Care Surg."},{"key":"119_CR117","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/10790268.1999.11719580","volume":"22","author":"JV Subbarao","year":"1999","unstructured":"Subbarao, J. V. & Garrison, S. J. Heterotopic ossification: diagnosis and management current concepts and controversies. J. Spinal Cord. Med. 22, 273\u2013283 (1999).","journal-title":"J. Spinal Cord. Med."},{"key":"119_CR118","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1302\/2046-3758.23.2000152","volume":"2","author":"M Sullivan","year":"2013","unstructured":"Sullivan, M., Torres, S., Mehta, S. & Ahn, J. Heterotopic ossification after central nervous system trauma: a current review. Bone Jt. Res. 2, 51\u201357 (2013).","journal-title":"Bone Jt. Res."},{"key":"119_CR119","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.rehab.2016.03.009","volume":"59","author":"W Almangour","year":"2016","unstructured":"Almangour, W. et al. Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: a systematic review. Ann. Phys. Rehabil. Med. 59, 263\u2013269 (2016).","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"119_CR120","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/HTR.0b013e31822b54ba","volume":"27","author":"F Genet","year":"2012","unstructured":"Genet, F. et al. Impact of the operative delay and the degree of neurologic sequelae on recurrence of excised heterotopic ossification in patients with traumatic brain injury. J. Head Trauma Rehabil. 27, 443\u2013448 (2012).","journal-title":"J. Head Trauma Rehabil."},{"key":"119_CR121","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sc.2015.20","volume":"53","author":"F Genet","year":"2015","unstructured":"Genet, F. et al. Beliefs relating to recurrence of heterotopic ossification following excision in patients with spinal cord injury: a review. Spinal Cord 53, 340\u2013344 (2015).","journal-title":"Spinal Cord"},{"key":"119_CR122","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1302\/0301-620X.91B11.22305","volume":"91","author":"F Gen\u00eat","year":"2009","unstructured":"Gen\u00eat, F. et al. Impact of late surgical intervention on heterotopic ossification of the hip after traumatic neurological injury. J. Bone Jt. Surg. Br. 91, 1493\u20131498 (2009).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR123","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5966\/sctm.2015-0365","volume":"6","author":"S Agarwal","year":"2017","unstructured":"Agarwal, S. et al. Surgical excision of heterotopic ossification leads to re-emergence of mesenchymal stem cell populations responsible for recurrence. Stem Cells Transl. Med. 6, 799\u2013806 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"119_CR124","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/00002060-200209000-00006","volume":"81","author":"E Melamed","year":"2002","unstructured":"Melamed, E. et al. Brain injury-related heterotopic bone formation: treatment strategy and results. Am. J. Phys. Med. Rehabil. 81, 670\u2013674 (2002).","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"119_CR125","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/sj.sc.3101309","volume":"40","author":"AA van Kuijk","year":"2002","unstructured":"van Kuijk, A. A., Geurts, A. C. H. & van Kuppevelt, H. J. M. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 40, 313\u2013326 (2002).","journal-title":"Spinal Cord"},{"key":"119_CR126","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11999-015-4266-1","volume":"473","author":"GJ Pavey","year":"2015","unstructured":"Pavey, G. J. et al. What risk factors predict recurrence of heterotopic ossification after excision in combat-related amputations? Clin. Orthop. Relat. Res. 473, 2814\u20132824 (2015).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"119_CR127","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ocl.2016.08.009","volume":"48","author":"WR Barfield","year":"2017","unstructured":"Barfield, W. R., Holmes, R. E. & Hartsock, L. A. Heterotopic ossification in trauma. Orthop. Clin. 48, 35\u201346 (2017).","journal-title":"Orthop. Clin."},{"key":"119_CR128","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2106\/00004623-200703000-00003","volume":"89","author":"BK Potter","year":"2007","unstructured":"Potter, B. K., Burns, T. C., Lacap, A. P., Granville, R. R. & Gajewski, D. A. Heterotopic ossification following traumatic and combat-related amputations: prevalence, risk factors, and preliminary results of excision. J. Bone Jt. Surg. Am. 89, 476\u2013486 (2007).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR129","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1302\/0301-620X.86B3.14480","volume":"86-B","author":"I Tsionos","year":"2004","unstructured":"Tsionos, I., Leclercq, C. & Rochet, J. M. Heterotopic ossification of the elbow in patients with burns. J. Bone Jt. Surg. Br. 86-B, 396\u2013403 (2004).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR130","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1667\/0033-7587(2003)159[0345:RISOTB]2.0.CO;2","volume":"159","author":"F Pohl","year":"2003","unstructured":"Pohl, F. et al. Radiation-induced suppression of the Bmp2 signal transduction pathway in the pluripotent mesenchymal cell line C2C12: an in vitro model for prevention of heterotopic ossification by radiotherapy. Radiat. Res. 159, 345\u2013350 (2003).","journal-title":"Radiat. Res."},{"key":"119_CR131","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bone.2003.09.003","volume":"34","author":"K Szymczyk","year":"2004","unstructured":"Szymczyk, K., Shapiro, I. & Adams, C. S. Ionizing radiation sensitizes bone cells to apoptosis. Bone 34, 148\u2013156 (2004).","journal-title":"Bone"},{"key":"119_CR132","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/00003086-197105000-00030","volume":"76","author":"PL Craven","year":"1971","unstructured":"Craven, P. L. & URIsT, M. R. Osteogenesis by radioisotope labelled cell populations in implants of bone matrix under the influence of ionizing radiation. Clin. Orthop. Relat. Res. 76, 231\u2013243 (1971).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"119_CR133","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.sc.3100847","volume":"38","author":"M Sautter-Bihl","year":"2000","unstructured":"Sautter-Bihl, M., Liebermeister, E. & Nanassy, A. Radiotherapy as a local treatment option for heterotopic ossifications in patients with spinal cord injury. Spinal Cord 38, 33\u201336 (2000).","journal-title":"Spinal Cord"},{"key":"119_CR134","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2106\/JBJS.I.01435","volume":"92","author":"N Hamid","year":"2010","unstructured":"Hamid, N. et al. Radiation therapy for heterotopic ossification prophylaxis acutely after elbow trauma: a prospective randomized study. J. Bone Jt. Surg. Am. 92, 2032\u20132038 (2010).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR135","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2106\/00004623-200112000-00003","volume":"83","author":"TA Burd","year":"2001","unstructured":"Burd, T. A., Lowry, K. J. & Anglen, J. O. Indomethacin compared with localized irradiation for the prevention of heterotopic ossification following surgical treatment of acetabular fractures. J. Bone Jt. Surg. Am. 83, 1783\u20131788 (2001).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-7-162","volume":"7","author":"F Haubner","year":"2012","unstructured":"Haubner, F., Ohmann, E., Pohl, F., Strutz, J. & Gassner, H. G. Wound healing after radiation therapy: review of the literature. Radiat. Oncol. 7, 162 (2012).","journal-title":"Radiat. Oncol."},{"key":"119_CR137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-7-140","volume":"7","author":"MK Farris","year":"2012","unstructured":"Farris, M. K., Chowdhry, V. K., Lemke, S., Kilpatrick, M. & Lacombe, M. Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification. Radiat. Oncol. 7, 1\u20136 (2012).","journal-title":"Radiat. Oncol."},{"key":"119_CR138","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.sc.3101166","volume":"39","author":"K Banovac","year":"2001","unstructured":"Banovac, K., Williams, J. M., Patrick, L. D. & Haniff, Y. M. Prevention of heterotopic ossification after spinal cord injury with indomethacin. Spinal Cord 39, 370\u2013374 (2001).","journal-title":"Spinal Cord"},{"key":"119_CR139","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/jor.1100090611","volume":"9","author":"PE DiCesare","year":"1991","unstructured":"DiCesare, P. E., Nimni, M. E., Peng, L., Yazdi, M. & Cheung, D. T. Effects of indomethacin on demineralized bone\u2010induced heterotopic ossification in the rat. J. Orthop. Res. 9, 855\u2013861 (1991).","journal-title":"J. Orthop. Res."},{"key":"119_CR140","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1503\/cmaj.1041606","volume":"171","author":"B Sibbald","year":"2004","unstructured":"Sibbald, B. Drug Regulation: Rofecoxib (Vioxx) voluntarily withdrawn from market. Can. Med. Assoc. J. 171, 1027\u20131028 (2004).","journal-title":"Can. Med. Assoc. J."},{"key":"119_CR141","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3109\/17453677608988744","volume":"47","author":"J R\u00f8","year":"1976","unstructured":"R\u00f8, J., Sudmann, E. & Marton, P. F. Effect of indomethacin on fracture healing in rats. Acta Orthop. Scand. 47, 588\u2013599 (1976).","journal-title":"Acta Orthop. Scand."},{"key":"119_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/1749-799X-4-12","volume":"4","author":"EO Baird","year":"2009","unstructured":"Baird, E. O. & Kang, Q. K. Prophylaxis of heterotopic ossification\u2013an updated review. J. Orthop. Surg. Res. 4, 12 (2009).","journal-title":"J. Orthop. Surg. Res."},{"key":"119_CR143","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.expneurol.2006.04.008","volume":"201","author":"KD Browne","year":"2006","unstructured":"Browne, K. D., Iwata, A., Putt, M. E. & Smith, D. H. Chronic ibuprofen administration worsens cognitive outcome following traumatic brain injury in rats. Exp. Neurol. 201, 301\u2013307 (2006).","journal-title":"Exp. Neurol."},{"key":"119_CR144","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/neu.2000.17.69","volume":"17","author":"PK Dash","year":"2000","unstructured":"Dash, P. K., Mach, S. A. & Moore, A. N. Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury. J. Neurotrauma 17, 69\u201381 (2000).","journal-title":"J. Neurotrauma"},{"key":"119_CR145","first-page":"247","volume":"59","author":"H Suleyman","year":"2007","unstructured":"Suleyman, H., Demircan, B. & Karagoz, Y. Anti-inflammatory and side effects of cyclo-oxygenase inhibitors. Pharmacol. Rep. 59, 247\u2013258 (2007).","journal-title":"Pharmacol. Rep."},{"key":"119_CR146","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1098-3597(01)90069-9","volume":"3","author":"GA Green","year":"2001","unstructured":"Green, G. A. Understanding NSAIDs: from aspirin to COX-2. Clin. Cornerstone 3, 50\u201359 (2001).","journal-title":"Clin. Cornerstone"},{"key":"119_CR147","doi-asserted-by":"crossref","unstructured":"Drake, M. T., Clarke, B. L. & Khosla, S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc. 83, 1032\u20131045 (2008).","DOI":"10.4065\/83.9.1032"},{"key":"119_CR148","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1542\/peds.2006-2023H","volume":"119","author":"RGG Russell","year":"2007","unstructured":"Russell, R. G. G. Bisphosphonates: mode of action and pharmacology. Pediatrics 119, S150\u2013S162 (2007).","journal-title":"Pediatrics"},{"key":"119_CR149","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jcms.2014.12.008","volume":"43","author":"FJ Manzano-Moreno","year":"2015","unstructured":"Manzano-Moreno, F. J., Ramos-Torrecillas, J., De Luna-Bertos, E., Ruiz, C. & Garc\u00eda-Mart\u00ednez, O. High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis. J. Cranio-Maxillofac. Surg. 43, 396\u2013401 (2015).","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"119_CR150","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","volume":"82","author":"AI Idris","year":"2008","unstructured":"Idris, A. I., Rojas, J., Greig, I. R., van\u2019t Hof, R. J. & Ralston, S. H. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif. Tissue Int. 82, 191\u2013201 (2008).","journal-title":"Calcif. Tissue Int."},{"key":"119_CR151","doi-asserted-by":"crossref","unstructured":"Garland, D. E., Alday, B., Venos, K. G. & Vogt, J. C. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin. Orthop. Relat. Res. 176, 197\u2013200 (1983).","DOI":"10.1097\/00003086-198306000-00028"},{"key":"119_CR152","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sc.1993.106","volume":"31","author":"K Banovac","year":"1993","unstructured":"Banovac, K., Gonzalez, F., Wade, N. & Bowker, J. J. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification. Spinal Cord 31, 660\u2013666 (1993).","journal-title":"Spinal Cord"},{"key":"119_CR153","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/10790268.1997.11719457","volume":"20","author":"K Banovac","year":"1997","unstructured":"Banovac, K., Gonzalez, F. & Renfree, K. J. Treatment of heterotopic ossification after spinal cord injury. J. Spinal Cord Med. 20, 60\u201365 (1997).","journal-title":"J. Spinal Cord Med."},{"key":"119_CR154","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1080\/10790268.2000.11753507","volume":"23","author":"K Banovac","year":"2000","unstructured":"Banovac, K. The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J. Spinal Cord Med. 23, 40\u201344 (2000).","journal-title":"J. Spinal Cord Med."},{"key":"119_CR155","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba, T. et al. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J. Bone Miner. Res. 15, 613\u2013620 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"119_CR156","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1359\/jbmr.1997.12.1.6","volume":"12","author":"DB Burr","year":"1997","unstructured":"Burr, D. B. et al. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J. Bone Miner. Res. 12, 6\u201315 (1997).","journal-title":"J. Bone Miner. Res."},{"key":"119_CR157","first-page":"159","volume":"10","author":"G Vasileiadis","year":"2010","unstructured":"Vasileiadis, G. et al. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin. J. Musculoskelet. Neuronal Interact. 10, 159\u2013165 (2010).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"119_CR158","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ydbio.2009.01.031","volume":"328","author":"JA Williams","year":"2009","unstructured":"Williams, J. A. et al. Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse. Dev. Biol. 328, 315\u2013327 (2009).","journal-title":"Dev. Biol."},{"key":"119_CR159","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bone.2016.06.014","volume":"90","author":"GJ Pavey","year":"2016","unstructured":"Pavey, G. J. et al. Targeted stimulation of retinoic acid receptor-\u03b3 mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model. Bone 90, 159\u2013167 (2016).","journal-title":"Bone"},{"key":"119_CR160","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nm.2334","volume":"17","author":"K Shimono","year":"2011","unstructured":"Shimono, K. et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-\u03b3 agonists. Nat. Med. 17, 454\u2013460 (2011).","journal-title":"Nat. Med."},{"key":"119_CR161","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1074\/jbc.M109.053926","volume":"285","author":"R Yasuhara","year":"2010","unstructured":"Yasuhara, R. et al. Wnt\/\u03b2-catenin and retinoic acid receptor signaling pathways interact to regulate chondrocyte function and matrix turnover. J. Biol. Chem. 285, 317\u2013327 (2010).","journal-title":"J. Biol. Chem."},{"key":"119_CR162","doi-asserted-by":"crossref","unstructured":"De Luca, F. et al. Retinoic acid is a potent regulator of growth plate chondrogenesis. Endocrinology 141, 346\u2013353 (2000).","DOI":"10.1210\/endo.141.1.7283"},{"key":"119_CR163","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nm.2334","volume":"17","author":"K Shimono","year":"2011","unstructured":"Shimono, K. et al. Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-gamma agonists. Nat. Med. 17, 454\u2013460 (2011).","journal-title":"Nat. Med."},{"key":"119_CR164","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bone.2016.06.014","volume":"90","author":"GJ Pavey","year":"2016","unstructured":"Pavey, G. J. et al. Targeted stimulation of retinoic acid receptor-gamma mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model. Bone 90, 159\u2013167 (2016).","journal-title":"Bone"},{"key":"119_CR165","first-page":"19","volume":"14","author":"J Reznik","year":"2014","unstructured":"Reznik, J. et al. Prevalence and risk-factors of neurogenic heterotopic ossification in traumatic spinal cord and traumatic brain injured patients admitted to specialised units in Australia. J. Musculoskelet. Neuronal Interact. 14, 19\u201328 (2014).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"119_CR166","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jbspin.2004.05.012","volume":"72","author":"P Rigaux","year":"2005","unstructured":"Rigaux, P. et al. Study of serum factors potentially involved in the pathogenesis of heterotopic bone formation after severe brain injury. Jt. Bone Spine 72, 146\u2013149 (2005).","journal-title":"Jt. Bone Spine"},{"key":"119_CR167","first-page":"459","volume":"73","author":"EA Hurvitz","year":"1992","unstructured":"Hurvitz, E. A., Mandac, B. R., Davidoff, G., Johnson, J. H. & Nelson, V. S. Risk factors for heterotopic ossification in children and adolescents with severe traumatic brain injury. Arch. Phys. Med. Rehabil. 73, 459\u2013462 (1992).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"119_CR168","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/0269215507075260","volume":"21","author":"HT Hendricks","year":"2007","unstructured":"Hendricks, H. T., Geurts, A., van Ginneken, B. C., Heeren, A. J. & Vos, P. E. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin. Rehabil. 21, 545\u2013553 (2007).","journal-title":"Clin. Rehabil."},{"key":"119_CR169","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00256-011-1115-5","volume":"41","author":"R Seipel","year":"2012","unstructured":"Seipel, R. et al. Neurogenic heterotopic ossification: epidemiology and morphology on conventional radiographs in an early neurological rehabilitation population. Skelet. Radiol. 41, 61\u201366 (2012).","journal-title":"Skelet. Radiol."},{"key":"119_CR170","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/S0003-9993(03)00347-2","volume":"84","author":"RS Singh","year":"2003","unstructured":"Singh, R. S., Craig, M. C., Katholi, C. R., Jackson, A. B. & Mountz, J. M. The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury. Arch. Phys. Med. Rehabil. 84, 1584\u20131588 (2003).","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"119_CR171","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1302\/0301-620X.74B2.1544955","volume":"74","author":"R Wittenberg","year":"1992","unstructured":"Wittenberg, R., Peschke, U. & Botel, U. Heterotopic ossification after spinal cord injury. Epidemiology and risk factors. J. Bone Jt. Surg. Br. 74, 215\u2013218 (1992).","journal-title":"J. Bone Jt. Surg. Br."},{"key":"119_CR172","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sc.1992.142","volume":"30","author":"P Bravo-Payno","year":"1992","unstructured":"Bravo-Payno, P., Esclarin, A., Arzoz, T., Arroyo, O. & Labarta, C. Incidence and risk factors in the appearance of heterotopic ossification in spinal cord injury. Spinal Cord 30, 740\u2013745 (1992).","journal-title":"Spinal Cord"},{"key":"119_CR173","first-page":"125","volume":"26","author":"JA Orzel","year":"1985","unstructured":"Orzel, J. A. & Rudd, T. G. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J. Nucl. Med. 26, 125\u2013132 (1985).","journal-title":"J. Nucl. Med."},{"key":"119_CR174","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.sc.3100415","volume":"35","author":"T Meiners","year":"1997","unstructured":"Meiners, T., Abel, R., B\u00f6hm, V. & Gerner, H. Resection of heterotopic ossification of the hip in spinal cord injured patients. Spinal Cord 35, 443\u2013445 (1997).","journal-title":"Spinal Cord"},{"key":"119_CR175","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/01.BCR.0000226023.58438.14","volume":"27","author":"JL Hunt","year":"2006","unstructured":"Hunt, J. L., Arnoldo, B. D., Kowalske, K., Helm, P. & Purdue, G. F. Heterotopic ossification revisited: a 21-year surgical experience. J. Burn Care Res. 27, 535\u2013540 (2006).","journal-title":"J. Burn Care Res."},{"key":"119_CR176","first-page":"151","volume":"61","author":"DA Stein","year":"2003","unstructured":"Stein, D. A. et al. Prevention of heterotopic ossification at the elbow following trauma using radiation therapy. Bull. Hosp. Jt. Dis. N.Y. 61, 151\u2013154 (2003).","journal-title":"Bull. Hosp. Jt. Dis. N.Y."},{"key":"119_CR177","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/sc.2016.112","volume":"55","author":"A M\u00fcseler","year":"2017","unstructured":"M\u00fcseler, A. et al. In-hospital outcomes following single-dose radiation therapy in the treatment of heterotopic ossification of the hip following spinal cord injury\u2014an analysis of 444 cases. Spinal Cord 55, 244\u2013246 (2017).","journal-title":"Spinal Cord"},{"key":"119_CR178","doi-asserted-by":"crossref","unstructured":"Cipriano, C., Pill, S. G., Rosenstock, J. & Keenan, M. A. Radiation therapy for preventing recurrence of neurogenic heterotopic ossification. Orthopedics 32, 685\u2013689 (2009).","DOI":"10.3928\/01477447-20090728-33"},{"key":"119_CR179","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.sc.3101628","volume":"42","author":"K Banovac","year":"2004","unstructured":"Banovac, K., Williams, J., Patrick, L. & Levi, A. Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib). Spinal Cord 42, 707\u2013710 (2004).","journal-title":"Spinal Cord"},{"key":"119_CR180","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0883-5403(03)00279-1","volume":"19","author":"CL Roman\u00f2","year":"2004","unstructured":"Roman\u00f2, C. L., Duci, D., Roman\u00f2, D., Mazza, M. & Meani, E. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J. Arthroplast. 19, 14\u201318 (2004).","journal-title":"J. Arthroplast."},{"key":"119_CR181","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2106\/00004623-198870060-00005","volume":"70","author":"SA Schmidt","year":"1988","unstructured":"Schmidt, S. A. et al. The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. A randomized, double-blind clinical trial. J. Bone Jt. Surg. Am. 70, 834\u2013838 (1988).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR182","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/0363546511434285","volume":"40","author":"A Bedi","year":"2012","unstructured":"Bedi, A. et al. The incidence of heterotopic ossification after hip arthroscopy. Am. J. Sports Med. 40, 854\u2013863 (2012).","journal-title":"Am. J. Sports Med."},{"key":"119_CR183","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2106\/JBJS.N.01156","volume":"97","author":"JT Beckmann","year":"2015","unstructured":"Beckmann, J. T. et al. Effect of naproxen prophylaxis on heterotopic ossification following hip arthroscopy: a double-blind randomized placebo-controlled trial. J. Bone Jt. Surg. Am. 97, 2032\u20132037 (2015).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"119_CR184","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/000164700317413085","volume":"71","author":"BC Neal","year":"2000","unstructured":"Neal, B. C. et al. No effect of low-dose aspirin for the prevention of heterotopic bone formation after total hip replacement: a randomized trial of 2\u2009649 patients. Acta Orthop. Scand. 71, 129\u2013134 (2000).","journal-title":"Acta Orthop. Scand."},{"key":"119_CR185","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.sc.3101761","volume":"43","author":"P Schuetz","year":"2005","unstructured":"Schuetz, P., Mueller, B., Christ-Crain, M., Dick, W. & Haas, H. Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases. Spinal Cord 43, 604\u2013610 (2005).","journal-title":"Spinal Cord"}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41413-020-00119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-020-00119-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41413-020-00119-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:31:56Z","timestamp":1670250716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41413-020-00119-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":185,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["119"],"URL":"https:\/\/doi.org\/10.1038\/s41413-020-00119-9","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}